Coskun, U. Et Al. 2004. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions. NEOPLASMA , vol.51, no.3 , 209-213.

Coskun, U., Bukan, N., Sancak, B., Gunel, N., Ozenirler, S., Unal, A., ... ATAK YÜCEL, A.(2004). Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions. NEOPLASMA , vol.51, no.3, 209-213.

Coskun, UĞUR Et Al. "Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions," NEOPLASMA , vol.51, no.3, 209-213, 2004

Coskun, UĞUR Et Al. "Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions." NEOPLASMA , vol.51, no.3, pp.209-213, 2004

Coskun, U. Et Al. (2004) . "Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions." NEOPLASMA , vol.51, no.3, pp.209-213.

@article{article, author={UĞUR COŞKUN Et Al. }, title={Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions}, journal={NEOPLASMA}, year=2004, pages={209-213} }